Adage Capital Partners Gp, L.L.C. Moderna, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Moderna, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 102,898 shares of MRNA stock, worth $4.07 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
102,898
Previous 252,453
59.24%
Holding current value
$4.07 Million
Previous $30 Million
77.06%
% of portfolio
0.01%
Previous 0.06%
Shares
14 transactions
Others Institutions Holding MRNA
# of Institutions
953Shares Held
240MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.68 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.59 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.01 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$667 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$286 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $15.5B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...